Prior year included discontinued operations. First half revenue $164.2m. Second half revenue $164.7m.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025